超聲檢查在預測不同部位的肝細胞肝癌術(shù)后復發(fā)率中的診斷價值分析
發(fā)布時間:2018-08-09 08:09
【摘要】:正肝細胞肝癌(HCC)是最常見的惡性腫瘤之一。我國是HCC的高發(fā)區(qū),每年約有十萬余人死于HCC。HCC復發(fā)是影響患者術(shù)后生存期的重要因素之一,不同腫瘤特征對術(shù)后復發(fā)率的影響不同[1]。本研究回顧性分析136例肝細胞肝癌患者術(shù)后的超聲影像資料,探討不同部位HCC的聲像圖特征與患者術(shù)后復發(fā)率之間的關(guān)系。1資料與方法1.1一般資料選擇2012年6月至2016年10月間本院超聲科診斷并經(jīng)術(shù)后病理證實的136例肝細胞肝癌手術(shù)患者為研究對象,男性87例,女性49例,年齡26
[Abstract]:Orthotopic hepatocellular carcinoma (HCC) is one of the most common malignant tumors. China is a high incidence area of HCC, about 100,000 people die of HCC.HCC recurrence every year is one of the important factors affecting the survival of patients after operation, different tumor characteristics have different effects on postoperative recurrence rate [1]. The ultrasonographic data of 136 patients with hepatocellular carcinoma after operation were analyzed retrospectively. To investigate the relationship between ultrasonographic features of HCC and postoperative recurrence rate of patients. 1 data and methods 1.1 General data selected 136 cases of liver cells diagnosed by ultrasound department and proved by postoperative pathology between June 2012 and October 2016 Patients undergoing liver cancer surgery were studied. 87 males, 49 females, age 26
【作者單位】: 海南西部中心醫(yī)院;
【分類號】:R445.1;R735.7
本文編號:2173460
[Abstract]:Orthotopic hepatocellular carcinoma (HCC) is one of the most common malignant tumors. China is a high incidence area of HCC, about 100,000 people die of HCC.HCC recurrence every year is one of the important factors affecting the survival of patients after operation, different tumor characteristics have different effects on postoperative recurrence rate [1]. The ultrasonographic data of 136 patients with hepatocellular carcinoma after operation were analyzed retrospectively. To investigate the relationship between ultrasonographic features of HCC and postoperative recurrence rate of patients. 1 data and methods 1.1 General data selected 136 cases of liver cells diagnosed by ultrasound department and proved by postoperative pathology between June 2012 and October 2016 Patients undergoing liver cancer surgery were studied. 87 males, 49 females, age 26
【作者單位】: 海南西部中心醫(yī)院;
【分類號】:R445.1;R735.7
【相似文獻】
相關(guān)期刊論文 前3條
1 錢海峰;林江;王青樂;諸一呂;張德生;;肝上皮樣血管平滑肌脂肪瘤和肝細胞肝癌的增強MR診斷[J];放射學實踐;2012年12期
2 宋朝虎;;肝細胞肝癌CT動態(tài)增強影像學表現(xiàn)形式與病理分化程度的相關(guān)性[J];貴州醫(yī)藥;2014年05期
3 夏燕娜;郭華;譚紅娜;姬麗娟;高劍波;;320排動態(tài)容積CT低劑量全肝灌注成像評價氬氦刀治療肝細胞肝癌20例近期療效[J];介入放射學雜志;2014年03期
相關(guān)博士學位論文 前2條
1 黃召勤;肝細胞肝癌3.0T MR成像特征與病理特點、Ki67和VEGF表達的相關(guān)性研究[D];山東大學;2015年
2 劉新疆;肝細胞癌術(shù)后轉(zhuǎn)移復發(fā)MR分子影像學特征與外周血腫瘤標志物表達調(diào)控的相關(guān)研究[D];山東大學;2014年
相關(guān)碩士學位論文 前3條
1 陸丹梅;彩色多普勒超聲檢測肝臟血流參數(shù)對肝細胞肝癌術(shù)后復發(fā)的預測價值研究[D];廣西醫(yī)科大學;2017年
2 薛明團;肝細胞肝癌擴散加權(quán)成像ADC值與KI-67的相關(guān)性研究[D];大連醫(yī)科大學;2016年
3 姜舒;CT能譜成像在肝細胞肝癌病理分化程度中的初步應(yīng)用[D];山東大學;2014年
,本文編號:2173460
本文鏈接:http://sikaile.net/yixuelunwen/fangshe/2173460.html
最近更新
教材專著